Portal de investigación
A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination with Other Anticancer Agents in Participants with Mature B-Cell. Malignancies.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
ASTRAZENECA AB C/O FORTREA
Cita
A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination with Other Anticancer Agents in Participants with Mature B-Cell. Malignancies. (D7407C00001). ASTRAZENECA AB C/O FORTREA. 2025IP:RAFAEL ANDREU LAPIEDRA.